Issuer to sell 50,000 Founders Shares (NASDAQ: CRWV)

Rhea-AI Filing Summary

Issuer files a Form 144 reporting a proposed resale of 50,000 Founders Shares. The notice lists multiple recent 10b5-1 and other sales of Common Stock executed in 2025 and 2026

The filing identifies recurring 10b5-1 sales by named holders (for example, Michael Intrator and Omnadora Capital LLC) with individual transactions of 32,455, 32,456, and 50,000 on several dates in 2026. The filing provides transaction dates and gross proceeds for each sale.

Insights

Securities Compliance Counsel

Form 144 lists a proposed resale of 50,000 Founders Shares and shows multiple recent 10b5-1 sales.

The filing documents a single proposed resale amount of 50,000 Founders Shares dated 11/13/2017 and detailed executed sales in 2025–2026 with per-trade counts and gross proceeds. It is a regulatory notice under resale rules rather than an issuer capital-raising.

The filing repeatedly references 10b5-1 sales by named sellers. Cash-flow treatment and whether the issuer receives proceeds are not stated in the excerpt; timing and any trading-plan disclosures should be confirmed in the full filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	4151000.00	419028081	03/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	03/11/2026	32455	2642135.59
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	03/11/2026	50000	4070460.00
Fidelity Charitable 245 Summer Street Boston MA 02210-1129	Common	03/05/2026	86710	6449923.35
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	02/25/2026	32456	3243824.66
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	02/25/2026	50000	4997265.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	02/11/2026	32455	3038833.05
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	02/11/2026	50000	4681610.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/28/2026	32456	3443055.81
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/28/2026	50000	5304190.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	32455	2901243.32
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	50000	4469640.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	61386	4674746.47
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	32456	2334725.61
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	78971	5731033.94
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	50000	3596755.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRWV Form 144 report?

The Form 144 reports a proposed resale of 50,000 Founders Shares and lists multiple executed sales of Common Stock in 2025–2026. The filing provides per‑trade share counts and gross proceeds but does not state proceeds treatment for the issuer.

Who executed recent 10b5-1 sales listed in the filing?

The filing names sellers including Michael Intrator and Omnadora Capital LLC, showing multiple 10b5-1 transactions of 32,455–50,000 shares on dates in 2026 with stated gross proceeds per trade.

Does the Form 144 show total proceeds from the sales?

The excerpt lists gross proceeds by individual transaction (for example, 4,070,460.00 for a 50,000-share sale) and provides per-trade amounts rather than an aggregate total for all listed transactions.

Are the reported sales part of a trading plan?

Several transactions are labeled 10b5-1 Sales, indicating they were executed under trading plans. The filing text shows those labels next to specific trades but does not include plan adoption dates in the provided excerpt.

Does Form 144 indicate the issuer will receive proceeds?

The provided excerpt does not state the cash-flow recipient. The filing lists resale transactions and gross proceeds per trade; whether proceeds go to the issuer or selling holders is not specified in the excerpt.